Total adiponectin in overweight and obese subjects and its response to visceral fat loss

Background Visceral obesity and related diabetes is reaching epidemic proportions in the United Arab Emirates (UAE). Adiponectin is a hormone that is secreted by adipose tissue and may play an important role in obesity-related morbidity. The aim of this study was to investigate total adiponectin lev...

Full description

Saved in:
Bibliographic Details
Published inBMC endocrine disorders Vol. 19; no. 1; pp. 55 - 6
Main Authors Gariballa, Salah, Alkaabi, Juma, Yasin, Javed, Al Essa, Awad
Format Journal Article
LanguageEnglish
Published London BioMed Central 03.06.2019
BioMed Central Ltd
BMC
Subjects
Online AccessGet full text
ISSN1472-6823
1472-6823
DOI10.1186/s12902-019-0386-z

Cover

Loading…
Abstract Background Visceral obesity and related diabetes is reaching epidemic proportions in the United Arab Emirates (UAE). Adiponectin is a hormone that is secreted by adipose tissue and may play an important role in obesity-related morbidity. The aim of this study was to investigate total adiponectin levels in overweight and obese UAE subjects visiting health care facilities for weight management. Methods All overweight and obese subjects visiting community health centers were invited to take part in the study. Two hundred and six participants received individualized structured dietary education for weight management. Demographic data, anthropometric measurements and fasting venous blood samples were taken for measurements of total adiponectin and markers of inflammation and nutritional status at baseline and follow up. Multivariate analysis was performed to determine the independent effects of prognostic factors on serum adiponectin levels. Results A total of 193 (93%) females with a mean age (±SD) 36 ± 11 years were included in the analysis. During a follow up period of 427 ± 223 days, participants received 13 ± 5 structured dietary education sessions. We observed decreased levels of total adiponectin with increasing quartiles of both waist circumference (WC) and body mass index (BMI). Male gender and history of both gestational and type 2 diabetes were associated with significantly lower total adiponectin levels ( p  < 0.05). After adjusting for age, gender, BMI and hip circumference, multiple regression analysis revealed a significant and independent association between waist circumference and total adiponectin levels. At follow up visceral fat loss was associated with a significant decrease in inflammatory markers and a non-significant increase in total adiponectin levels. Conclusion Increased visceral fat in overweight and obese subjects is associated with decreased total adiponectin levels. The health benefits of increasing adiponectin levels using different dietary intervention strategies need to be explored in larger studies. Trial registration NCT01691365 , registered on 11/09/2012.
AbstractList Background Visceral obesity and related diabetes is reaching epidemic proportions in the United Arab Emirates (UAE). Adiponectin is a hormone that is secreted by adipose tissue and may play an important role in obesity-related morbidity. The aim of this study was to investigate total adiponectin levels in overweight and obese UAE subjects visiting health care facilities for weight management. Methods All overweight and obese subjects visiting community health centers were invited to take part in the study. Two hundred and six participants received individualized structured dietary education for weight management. Demographic data, anthropometric measurements and fasting venous blood samples were taken for measurements of total adiponectin and markers of inflammation and nutritional status at baseline and follow up. Multivariate analysis was performed to determine the independent effects of prognostic factors on serum adiponectin levels. Results A total of 193 (93%) females with a mean age ([+ or -]SD) 36 [+ or -] 11 years were included in the analysis. During a follow up period of 427 [+ or -] 223 days, participants received 13 [+ or -] 5 structured dietary education sessions. We observed decreased levels of total adiponectin with increasing quartiles of both waist circumference (WC) and body mass index (BMI). Male gender and history of both gestational and type 2 diabetes were associated with significantly lower total adiponectin levels (p < 0.05). After adjusting for age, gender, BMI and hip circumference, multiple regression analysis revealed a significant and independent association between waist circumference and total adiponectin levels. At follow up visceral fat loss was associated with a significant decrease in inflammatory markers and a non-significant increase in total adiponectin levels. Conclusion Increased visceral fat in overweight and obese subjects is associated with decreased total adiponectin levels. The health benefits of increasing adiponectin levels using different dietary intervention strategies need to be explored in larger studies. Trial registration NCT01691365, registered on 11/09/2012. Keywords: Adiponectin, Obesity, Visceral fat, Diet
Visceral obesity and related diabetes is reaching epidemic proportions in the United Arab Emirates (UAE). Adiponectin is a hormone that is secreted by adipose tissue and may play an important role in obesity-related morbidity. The aim of this study was to investigate total adiponectin levels in overweight and obese UAE subjects visiting health care facilities for weight management. All overweight and obese subjects visiting community health centers were invited to take part in the study. Two hundred and six participants received individualized structured dietary education for weight management. Demographic data, anthropometric measurements and fasting venous blood samples were taken for measurements of total adiponectin and markers of inflammation and nutritional status at baseline and follow up. Multivariate analysis was performed to determine the independent effects of prognostic factors on serum adiponectin levels. A total of 193 (93%) females with a mean age ([+ or -]SD) 36 [+ or -] 11 years were included in the analysis. During a follow up period of 427 [+ or -] 223 days, participants received 13 [+ or -] 5 structured dietary education sessions. We observed decreased levels of total adiponectin with increasing quartiles of both waist circumference (WC) and body mass index (BMI). Male gender and history of both gestational and type 2 diabetes were associated with significantly lower total adiponectin levels (p < 0.05). After adjusting for age, gender, BMI and hip circumference, multiple regression analysis revealed a significant and independent association between waist circumference and total adiponectin levels. At follow up visceral fat loss was associated with a significant decrease in inflammatory markers and a non-significant increase in total adiponectin levels. Increased visceral fat in overweight and obese subjects is associated with decreased total adiponectin levels. The health benefits of increasing adiponectin levels using different dietary intervention strategies need to be explored in larger studies.
Visceral obesity and related diabetes is reaching epidemic proportions in the United Arab Emirates (UAE). Adiponectin is a hormone that is secreted by adipose tissue and may play an important role in obesity-related morbidity. The aim of this study was to investigate total adiponectin levels in overweight and obese UAE subjects visiting health care facilities for weight management. All overweight and obese subjects visiting community health centers were invited to take part in the study. Two hundred and six participants received individualized structured dietary education for weight management. Demographic data, anthropometric measurements and fasting venous blood samples were taken for measurements of total adiponectin and markers of inflammation and nutritional status at baseline and follow up. Multivariate analysis was performed to determine the independent effects of prognostic factors on serum adiponectin levels. A total of 193 (93%) females with a mean age (±SD) 36 ± 11 years were included in the analysis. During a follow up period of 427 ± 223 days, participants received 13 ± 5 structured dietary education sessions. We observed decreased levels of total adiponectin with increasing quartiles of both waist circumference (WC) and body mass index (BMI). Male gender and history of both gestational and type 2 diabetes were associated with significantly lower total adiponectin levels (p < 0.05). After adjusting for age, gender, BMI and hip circumference, multiple regression analysis revealed a significant and independent association between waist circumference and total adiponectin levels. At follow up visceral fat loss was associated with a significant decrease in inflammatory markers and a non-significant increase in total adiponectin levels. Increased visceral fat in overweight and obese subjects is associated with decreased total adiponectin levels. The health benefits of increasing adiponectin levels using different dietary intervention strategies need to be explored in larger studies. NCT01691365 , registered on 11/09/2012.
Background Visceral obesity and related diabetes is reaching epidemic proportions in the United Arab Emirates (UAE). Adiponectin is a hormone that is secreted by adipose tissue and may play an important role in obesity-related morbidity. The aim of this study was to investigate total adiponectin levels in overweight and obese UAE subjects visiting health care facilities for weight management. Methods All overweight and obese subjects visiting community health centers were invited to take part in the study. Two hundred and six participants received individualized structured dietary education for weight management. Demographic data, anthropometric measurements and fasting venous blood samples were taken for measurements of total adiponectin and markers of inflammation and nutritional status at baseline and follow up. Multivariate analysis was performed to determine the independent effects of prognostic factors on serum adiponectin levels. Results A total of 193 (93%) females with a mean age (±SD) 36 ± 11 years were included in the analysis. During a follow up period of 427 ± 223 days, participants received 13 ± 5 structured dietary education sessions. We observed decreased levels of total adiponectin with increasing quartiles of both waist circumference (WC) and body mass index (BMI). Male gender and history of both gestational and type 2 diabetes were associated with significantly lower total adiponectin levels (p < 0.05). After adjusting for age, gender, BMI and hip circumference, multiple regression analysis revealed a significant and independent association between waist circumference and total adiponectin levels. At follow up visceral fat loss was associated with a significant decrease in inflammatory markers and a non-significant increase in total adiponectin levels. Conclusion Increased visceral fat in overweight and obese subjects is associated with decreased total adiponectin levels. The health benefits of increasing adiponectin levels using different dietary intervention strategies need to be explored in larger studies. Trial registration NCT01691365, registered on 11/09/2012.
Abstract Background Visceral obesity and related diabetes is reaching epidemic proportions in the United Arab Emirates (UAE). Adiponectin is a hormone that is secreted by adipose tissue and may play an important role in obesity-related morbidity. The aim of this study was to investigate total adiponectin levels in overweight and obese UAE subjects visiting health care facilities for weight management. Methods All overweight and obese subjects visiting community health centers were invited to take part in the study. Two hundred and six participants received individualized structured dietary education for weight management. Demographic data, anthropometric measurements and fasting venous blood samples were taken for measurements of total adiponectin and markers of inflammation and nutritional status at baseline and follow up. Multivariate analysis was performed to determine the independent effects of prognostic factors on serum adiponectin levels. Results A total of 193 (93%) females with a mean age (±SD) 36 ± 11 years were included in the analysis. During a follow up period of 427 ± 223 days, participants received 13 ± 5 structured dietary education sessions. We observed decreased levels of total adiponectin with increasing quartiles of both waist circumference (WC) and body mass index (BMI). Male gender and history of both gestational and type 2 diabetes were associated with significantly lower total adiponectin levels (p < 0.05). After adjusting for age, gender, BMI and hip circumference, multiple regression analysis revealed a significant and independent association between waist circumference and total adiponectin levels. At follow up visceral fat loss was associated with a significant decrease in inflammatory markers and a non-significant increase in total adiponectin levels. Conclusion Increased visceral fat in overweight and obese subjects is associated with decreased total adiponectin levels. The health benefits of increasing adiponectin levels using different dietary intervention strategies need to be explored in larger studies. Trial registration NCT01691365, registered on 11/09/2012.
Visceral obesity and related diabetes is reaching epidemic proportions in the United Arab Emirates (UAE). Adiponectin is a hormone that is secreted by adipose tissue and may play an important role in obesity-related morbidity. The aim of this study was to investigate total adiponectin levels in overweight and obese UAE subjects visiting health care facilities for weight management.BACKGROUNDVisceral obesity and related diabetes is reaching epidemic proportions in the United Arab Emirates (UAE). Adiponectin is a hormone that is secreted by adipose tissue and may play an important role in obesity-related morbidity. The aim of this study was to investigate total adiponectin levels in overweight and obese UAE subjects visiting health care facilities for weight management.All overweight and obese subjects visiting community health centers were invited to take part in the study. Two hundred and six participants received individualized structured dietary education for weight management. Demographic data, anthropometric measurements and fasting venous blood samples were taken for measurements of total adiponectin and markers of inflammation and nutritional status at baseline and follow up. Multivariate analysis was performed to determine the independent effects of prognostic factors on serum adiponectin levels.METHODSAll overweight and obese subjects visiting community health centers were invited to take part in the study. Two hundred and six participants received individualized structured dietary education for weight management. Demographic data, anthropometric measurements and fasting venous blood samples were taken for measurements of total adiponectin and markers of inflammation and nutritional status at baseline and follow up. Multivariate analysis was performed to determine the independent effects of prognostic factors on serum adiponectin levels.A total of 193 (93%) females with a mean age (±SD) 36 ± 11 years were included in the analysis. During a follow up period of 427 ± 223 days, participants received 13 ± 5 structured dietary education sessions. We observed decreased levels of total adiponectin with increasing quartiles of both waist circumference (WC) and body mass index (BMI). Male gender and history of both gestational and type 2 diabetes were associated with significantly lower total adiponectin levels (p < 0.05). After adjusting for age, gender, BMI and hip circumference, multiple regression analysis revealed a significant and independent association between waist circumference and total adiponectin levels. At follow up visceral fat loss was associated with a significant decrease in inflammatory markers and a non-significant increase in total adiponectin levels.RESULTSA total of 193 (93%) females with a mean age (±SD) 36 ± 11 years were included in the analysis. During a follow up period of 427 ± 223 days, participants received 13 ± 5 structured dietary education sessions. We observed decreased levels of total adiponectin with increasing quartiles of both waist circumference (WC) and body mass index (BMI). Male gender and history of both gestational and type 2 diabetes were associated with significantly lower total adiponectin levels (p < 0.05). After adjusting for age, gender, BMI and hip circumference, multiple regression analysis revealed a significant and independent association between waist circumference and total adiponectin levels. At follow up visceral fat loss was associated with a significant decrease in inflammatory markers and a non-significant increase in total adiponectin levels.Increased visceral fat in overweight and obese subjects is associated with decreased total adiponectin levels. The health benefits of increasing adiponectin levels using different dietary intervention strategies need to be explored in larger studies.CONCLUSIONIncreased visceral fat in overweight and obese subjects is associated with decreased total adiponectin levels. The health benefits of increasing adiponectin levels using different dietary intervention strategies need to be explored in larger studies.NCT01691365 , registered on 11/09/2012.TRIAL REGISTRATIONNCT01691365 , registered on 11/09/2012.
Background Visceral obesity and related diabetes is reaching epidemic proportions in the United Arab Emirates (UAE). Adiponectin is a hormone that is secreted by adipose tissue and may play an important role in obesity-related morbidity. The aim of this study was to investigate total adiponectin levels in overweight and obese UAE subjects visiting health care facilities for weight management. Methods All overweight and obese subjects visiting community health centers were invited to take part in the study. Two hundred and six participants received individualized structured dietary education for weight management. Demographic data, anthropometric measurements and fasting venous blood samples were taken for measurements of total adiponectin and markers of inflammation and nutritional status at baseline and follow up. Multivariate analysis was performed to determine the independent effects of prognostic factors on serum adiponectin levels. Results A total of 193 (93%) females with a mean age (±SD) 36 ± 11 years were included in the analysis. During a follow up period of 427 ± 223 days, participants received 13 ± 5 structured dietary education sessions. We observed decreased levels of total adiponectin with increasing quartiles of both waist circumference (WC) and body mass index (BMI). Male gender and history of both gestational and type 2 diabetes were associated with significantly lower total adiponectin levels ( p  < 0.05). After adjusting for age, gender, BMI and hip circumference, multiple regression analysis revealed a significant and independent association between waist circumference and total adiponectin levels. At follow up visceral fat loss was associated with a significant decrease in inflammatory markers and a non-significant increase in total adiponectin levels. Conclusion Increased visceral fat in overweight and obese subjects is associated with decreased total adiponectin levels. The health benefits of increasing adiponectin levels using different dietary intervention strategies need to be explored in larger studies. Trial registration NCT01691365 , registered on 11/09/2012.
ArticleNumber 55
Audience Academic
Author Yasin, Javed
Gariballa, Salah
Alkaabi, Juma
Al Essa, Awad
Author_xml – sequence: 1
  givenname: Salah
  surname: Gariballa
  fullname: Gariballa, Salah
  email: s.gariballa@uaeu.ac.ae
  organization: Department of Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University
– sequence: 2
  givenname: Juma
  surname: Alkaabi
  fullname: Alkaabi, Juma
  organization: Department of Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University
– sequence: 3
  givenname: Javed
  surname: Yasin
  fullname: Yasin, Javed
  organization: Department of Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University
– sequence: 4
  givenname: Awad
  surname: Al Essa
  fullname: Al Essa, Awad
  organization: Department of Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31159801$$D View this record in MEDLINE/PubMed
BookMark eNp9kl9rFDEUxQep2Hb1A_giA774MjV_JsnkRSjFaqHgSwXfwk0ms80yO1mT7Ir99L3bbW23qMxAws05v3Bu7nF1MMXJV9VbSk4o7eTHTJkmrCFUN4R3srl5UR3RVrFGdowfPNkfVsc5LwihqmPkVXXIKRW6I_So-nEVC4w19GGFbFfCVOMfNz798mF-XWqY-jpan32d13aBinxXCrgmn9GEJyXWm5CdT0gaoNRjzPl19XKAMfs39-us-n7--ersa3P57cvF2ell4yThpaFMAiM9U0r31kqi-dAPTPNuIFa2TvScW85074TsHCgrQA-kVZQBaPBE8Vl1seP2ERZmlcIS0m8TIZi7QkxzA6kEN3pjPVBNJQiheMs12EFRUJ53WljhKUPWpx1rtbZL3zs_FYy0B90_mcK1mceNkaIVinUI-HAPSPHn2udiltu-jCNMPq6zYYwLoijB62fV-2fSRVynCVuFqhYjC9GyR9UcMECYhoj3ui3UnApNFGs7IlF18hcVfr1fBofvOgSs7xnePQ36J-HDXKBA7QQu4VsmPxgXCpQQt7nDaCgx2wk0uwk0OIFmO4HmBp30mfMB_j8P23kyaqe5T4-9-LfpFkWT7HA
CitedBy_id crossref_primary_10_1111_iju_14476
crossref_primary_10_1055_s_0042_1755450
crossref_primary_10_3390_medicina58091271
crossref_primary_10_1016_j_jtcme_2023_03_005
crossref_primary_10_3390_ijms24021455
crossref_primary_10_1016_j_jstrokecerebrovasdis_2021_105993
crossref_primary_10_1016_j_jot_2020_07_004
crossref_primary_10_1016_j_coph_2020_06_003
crossref_primary_10_1111_eci_14328
crossref_primary_10_3390_medicina58121768
crossref_primary_10_3389_fncel_2023_1294420
crossref_primary_10_3390_nu14214683
crossref_primary_10_1186_s13075_024_03317_6
crossref_primary_10_3390_metabo14050260
crossref_primary_10_4103_ijnpnd_ijnpnd_89_20
crossref_primary_10_1016_j_jhep_2020_10_030
crossref_primary_10_2147_DMSO_S256864
crossref_primary_10_2147_DMSO_S338254
crossref_primary_10_3233_MNM_200502
crossref_primary_10_4103_JCMRP_JCMRP_37_20
crossref_primary_10_1186_s12872_024_03865_4
crossref_primary_10_3389_fendo_2025_1527567
crossref_primary_10_34287_MMT_1_44__2020_8
crossref_primary_10_1007_s00018_023_04834_4
crossref_primary_10_1093_nutrit_nuad174
crossref_primary_10_1186_s13578_021_00587_4
crossref_primary_10_3390_ijms20153657
crossref_primary_10_3390_cancers13205067
crossref_primary_10_3390_antiox10020260
crossref_primary_10_3390_ijerph19010449
crossref_primary_10_3390_nu16183170
crossref_primary_10_1016_j_matbio_2022_08_006
crossref_primary_10_1186_s12902_022_01020_8
crossref_primary_10_1158_1055_9965_EPI_24_1067
crossref_primary_10_3390_diagnostics11010138
crossref_primary_10_1186_s12931_023_02569_1
crossref_primary_10_1007_s11914_024_00884_0
crossref_primary_10_3390_antiox12040826
crossref_primary_10_1016_j_mehy_2023_111241
crossref_primary_10_2139_ssrn_4187671
crossref_primary_10_4103_ejdv_ejdv_6_23
crossref_primary_10_1007_s11064_022_03817_4
crossref_primary_10_3390_cancers13040778
crossref_primary_10_1016_j_ibmed_2025_100236
crossref_primary_10_3389_fphar_2024_1457280
crossref_primary_10_3390_jcm10081693
crossref_primary_10_1016_j_jtumed_2023_01_009
crossref_primary_10_1016_j_jff_2023_105465
crossref_primary_10_3389_fendo_2022_873699
crossref_primary_10_1007_s12020_023_03339_1
crossref_primary_10_1016_j_envres_2022_114654
crossref_primary_10_3390_arm92060048
crossref_primary_10_5334_paah_400
crossref_primary_10_1096_fj_202200498R
crossref_primary_10_1111_liv_15377
crossref_primary_10_1089_met_2021_0141
crossref_primary_10_1177_11786388241297143
crossref_primary_10_3389_fneur_2024_1398907
crossref_primary_10_1002_fsn3_3130
crossref_primary_10_1016_j_numecd_2022_01_001
crossref_primary_10_1017_S0007114522001428
crossref_primary_10_1093_ageing_afae041
crossref_primary_10_20538_1682_0363_2023_4_48_56
crossref_primary_10_1017_S0007114521000970
crossref_primary_10_1038_s41584_024_01143_3
crossref_primary_10_3390_life12020272
crossref_primary_10_3390_cells11172725
crossref_primary_10_3390_molecules28041964
crossref_primary_10_3390_ijms222413529
crossref_primary_10_1016_j_envres_2021_111905
crossref_primary_10_1159_000531614
crossref_primary_10_1177_20420188231222371
crossref_primary_10_1186_s12920_022_01420_8
crossref_primary_10_3390_nu13051394
crossref_primary_10_1007_s13679_024_00588_7
crossref_primary_10_3390_nu15071722
crossref_primary_10_3389_falgy_2024_1365801
crossref_primary_10_3390_ijms22010201
crossref_primary_10_3390_jpm14091008
crossref_primary_10_3390_cancers12071849
crossref_primary_10_1016_j_nbd_2024_106715
crossref_primary_10_1038_s41585_023_00764_9
crossref_primary_10_1016_j_dsx_2021_102214
crossref_primary_10_1016_j_jsbmb_2021_105925
crossref_primary_10_2147_DMSO_S265879
crossref_primary_10_3389_fendo_2023_1171675
crossref_primary_10_1111_jce_15604
crossref_primary_10_1016_j_bcp_2023_116012
crossref_primary_10_3390_jcm14051770
crossref_primary_10_3390_ijerph19116908
crossref_primary_10_20473_mgk_v11i1_2022_298_306
crossref_primary_10_4103_njbcs_njbcs_40_22
crossref_primary_10_15407_ubj94_03_039
crossref_primary_10_3390_ijms252312637
crossref_primary_10_7762_cnr_2024_13_2_121
crossref_primary_10_1186_s12944_024_02425_1
Cites_doi 10.1507/endocrj.K06-021
10.1186/1475-2891-12-146
10.1016/S0140-6736(04)17018-9
10.1055/s-2005-870580
10.1016/j.cyto.2016.06.028
10.1016/S0140-6736(03)15268-3
10.1038/ijo.2011.167
10.1210/jc.2016-1207
10.1111/bph.13619
10.3803/EnM.2013.28.3.169
10.3390/nu6114872
10.15537/smj.2017.9.19629
10.1159/000351162
10.1136/bmj.g3576
10.1016/j.diabres.2004.12.005
10.1093/jmcb/mjw011
10.1186/1475-2840-12-170
10.1177/2042018815577039
10.3945/jn.114.202432
ContentType Journal Article
Copyright The Author(s). 2019
COPYRIGHT 2019 BioMed Central Ltd.
2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s). 2019
– notice: COPYRIGHT 2019 BioMed Central Ltd.
– notice: 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QP
7TK
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12902-019-0386-z
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database ProQuest
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

MEDLINE
Publicly Available Content Database

MEDLINE - Academic

Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Education
Statistics
EISSN 1472-6823
EndPage 6
ExternalDocumentID oai_doaj_org_article_bea1916a5573439abf71a7e3895b5e12
PMC6545728
A590724806
31159801
10_1186_s12902_019_0386_z
Genre Journal Article
GeographicLocations United Arab Emirates
GeographicLocations_xml – name: United Arab Emirates
GrantInformation_xml – fundername: Al Jalila Foundation
  grantid: AJF201608
  funderid: http://dx.doi.org/10.13039/100012001
– fundername: Al Jalila Foundation
  grantid: AJF201608
– fundername: ;
  grantid: AJF201608
GroupedDBID ---
0R~
23N
2WC
53G
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
E3Z
EBD
EBLON
EBS
EJD
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
~8M
AAYXX
ALIPV
CITATION
-A0
3V.
ACRMQ
ADINQ
C24
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
7QP
7TK
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c603t-126a20d2779dbb6093fdf2938f0b64c5d33b329dc568ca7b5a9f04712aa9ae073
IEDL.DBID M48
ISSN 1472-6823
IngestDate Wed Aug 27 01:25:30 EDT 2025
Thu Aug 21 18:18:38 EDT 2025
Fri Sep 05 00:00:32 EDT 2025
Fri Jul 25 04:58:22 EDT 2025
Tue Jun 17 21:06:51 EDT 2025
Tue Jun 10 20:42:28 EDT 2025
Thu Jan 02 22:59:28 EST 2025
Tue Jul 01 01:37:12 EDT 2025
Thu Apr 24 23:01:36 EDT 2025
Sat Sep 06 07:29:46 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Visceral fat
Obesity
Diet
Adiponectin
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c603t-126a20d2779dbb6093fdf2938f0b64c5d33b329dc568ca7b5a9f04712aa9ae073
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12902-019-0386-z
PMID 31159801
PQID 2243295542
PQPubID 44656
PageCount 6
ParticipantIDs doaj_primary_oai_doaj_org_article_bea1916a5573439abf71a7e3895b5e12
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6545728
proquest_miscellaneous_2235071034
proquest_journals_2243295542
gale_infotracmisc_A590724806
gale_infotracacademiconefile_A590724806
pubmed_primary_31159801
crossref_citationtrail_10_1186_s12902_019_0386_z
crossref_primary_10_1186_s12902_019_0386_z
springer_journals_10_1186_s12902_019_0386_z
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-06-03
PublicationDateYYYYMMDD 2019-06-03
PublicationDate_xml – month: 06
  year: 2019
  text: 2019-06-03
  day: 03
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle BMC endocrine disorders
PublicationTitleAbbrev BMC Endocr Disord
PublicationTitleAlternate BMC Endocr Disord
PublicationYear 2019
Publisher BioMed Central
BioMed Central Ltd
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: BMC
References MJ Hosseinzadeh-Attar (386_CR13) 2013; 6
WF Ferris (386_CR14) 2005; 37
WHO Expert Consultation (386_CR6) 2004; 363
A Shah (386_CR15) 2012; 36
National Institute for Health and Care Excellence (386_CR21) 2014
S Yusuf (386_CR7) 2004; 364
ZV Wang (386_CR8) 2016; 8
386_CR1
W Ma (386_CR22) 2016; 101
S Gariballa (386_CR5) 2017; 38
C Liu (386_CR17) 2016; 86
DC Sulistyoningrum (386_CR10) 2013; 12
P Barter (386_CR19) 2013; 28
A Malik (386_CR3) 2005; 69
P Lopez-Jaramillo (386_CR11) 2016; 146
The Report of a British Nutrition Foundation Task Force (386_CR2) 2005
L Woodward (386_CR9) 2017; 174
MR Al-Badri (386_CR16) 2015; 6
S Gariballa (386_CR4) 2014; 6
AE Altinova (386_CR18) 2007; 54
N Hawkes (386_CR20) 2014; 348
KA Varady (386_CR12) 2013; 12
References_xml – volume: 54
  start-page: 221
  issue: 2
  year: 2007
  ident: 386_CR18
  publication-title: Endocr J
  doi: 10.1507/endocrj.K06-021
– volume: 12
  start-page: 146
  year: 2013
  ident: 386_CR12
  publication-title: Nutr J
  doi: 10.1186/1475-2891-12-146
– volume: 364
  start-page: 937
  year: 2004
  ident: 386_CR7
  publication-title: Lancet
  doi: 10.1016/S0140-6736(04)17018-9
– volume: 37
  start-page: 695
  issue: 11
  year: 2005
  ident: 386_CR14
  publication-title: Horm Metab Res
  doi: 10.1055/s-2005-870580
– volume: 86
  start-page: 100
  year: 2016
  ident: 386_CR17
  publication-title: Cytokine.
  doi: 10.1016/j.cyto.2016.06.028
– volume: 363
  start-page: 157
  year: 2004
  ident: 386_CR6
  publication-title: Lancet
  doi: 10.1016/S0140-6736(03)15268-3
– volume: 36
  start-page: 810
  issue: 6
  year: 2012
  ident: 386_CR15
  publication-title: Int J Obes
  doi: 10.1038/ijo.2011.167
– volume: 101
  start-page: 2415
  issue: 6
  year: 2016
  ident: 386_CR22
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2016-1207
– volume-title: Managing overweight and obesity in adults—lifestyle weight management services
  year: 2014
  ident: 386_CR21
– volume: 174
  start-page: 4007
  issue: 22
  year: 2017
  ident: 386_CR9
  publication-title: Br J Pharmacol
  doi: 10.1111/bph.13619
– volume: 28
  start-page: 169
  year: 2013
  ident: 386_CR19
  publication-title: Endocrinol Metab
  doi: 10.3803/EnM.2013.28.3.169
– volume-title: Cardiovascular disease, Diet, Nutrition and Emerging Risk Factors
  year: 2005
  ident: 386_CR2
– volume: 6
  start-page: 4872
  issue: 11
  year: 2014
  ident: 386_CR4
  publication-title: Nutrients.
  doi: 10.3390/nu6114872
– volume: 38
  start-page: 960
  issue: 9
  year: 2017
  ident: 386_CR5
  publication-title: Saudi Med J
  doi: 10.15537/smj.2017.9.19629
– volume: 6
  start-page: 193
  issue: 2
  year: 2013
  ident: 386_CR13
  publication-title: Obes Facts
  doi: 10.1159/000351162
– ident: 386_CR1
– volume: 348
  start-page: g3576
  year: 2014
  ident: 386_CR20
  publication-title: BMJ
  doi: 10.1136/bmj.g3576
– volume: 69
  start-page: 188
  year: 2005
  ident: 386_CR3
  publication-title: Diabetes Res Clin Pract
  doi: 10.1016/j.diabres.2004.12.005
– volume: 8
  start-page: 93
  issue: 2
  year: 2016
  ident: 386_CR8
  publication-title: J Mol Cell Biol
  doi: 10.1093/jmcb/mjw011
– volume: 12
  start-page: 170
  year: 2013
  ident: 386_CR10
  publication-title: Cardiovasc Diabetol
  doi: 10.1186/1475-2840-12-170
– volume: 6
  start-page: 103
  issue: 3
  year: 2015
  ident: 386_CR16
  publication-title: Ther Adv Endocrinol Metab
  doi: 10.1177/2042018815577039
– volume: 146
  start-page: 422S
  issue: 2
  year: 2016
  ident: 386_CR11
  publication-title: J Nutr
  doi: 10.3945/jn.114.202432
SSID ssj0017820
Score 2.4715068
Snippet Background Visceral obesity and related diabetes is reaching epidemic proportions in the United Arab Emirates (UAE). Adiponectin is a hormone that is secreted...
Visceral obesity and related diabetes is reaching epidemic proportions in the United Arab Emirates (UAE). Adiponectin is a hormone that is secreted by adipose...
Background Visceral obesity and related diabetes is reaching epidemic proportions in the United Arab Emirates (UAE). Adiponectin is a hormone that is secreted...
Abstract Background Visceral obesity and related diabetes is reaching epidemic proportions in the United Arab Emirates (UAE). Adiponectin is a hormone that is...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 55
SubjectTerms Adiponectin
Adiponectin - blood
Adipose tissue
Adolescent
Adult
Analysis
Asian people
Basic and Clinical Endocrinology
Biomarkers - blood
Body Composition
Body Mass Index
Body weight
Cardiovascular disease
Care and treatment
Chronic illnesses
Community health services
Composition
Cytokines
Diabetes
Diabetes mellitus
Diabetes mellitus (non-insulin dependent)
Diagnosis
Diet
Education
Endocrinology
Fasting
Female
Follow-Up Studies
Gastrointestinal surgery
Gender
Health aspects
Hip
Hormones
Humans
Incidence
Inflammation
Insulin resistance
Intervention
Intra-Abdominal Fat - physiopathology
Longitudinal Studies
Male
Medicine
Medicine & Public Health
Metabolic Diseases
Molecular weight
Morbidity
Multiple regression analysis
Multivariate analysis
Nutritional status
Obesity
Obesity - blood
Obesity - diagnosis
Obesity - epidemiology
Overweight
Overweight - blood
Overweight - diagnosis
Overweight - epidemiology
Population
Prognosis
Prospective Studies
Regression analysis
Research Article
Retirement benefits
rology
Statistics
Studies
Systematic review
Type 2 diabetes
United Arab Emirates - epidemiology
Visceral fat
Waist Circumference
Weight control
Young Adult
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1baxQxFA7SB_FFvDtaJYIgKEMzyeT2WMVSBH1qYd9CboMLZaZ0dn3or_eczOzaqagvwsLCJMPm3HK-JGe_EPIWJv1sYufrLua2bpPlteeNqEOULJoAoNyXaotv6vS8_bKSqxtXfWFN2EQPPCnuKGQPSwrlpdQCkqcPnW68zpBnZZC53C_MmWW7xdR8foAscPMZZmPU0Yi7LViCYGsmjKqvF1mokPX_PiXfyEm36yVvHZqWXHTygNyfQSQ9ngb_kNzJ_SNy9-t8TP6YrM4GwNTUp_Xl0OOM1lP4DKUGGhfj1PeJDiGPmY7bgDsxY3m0hu-rqWg2081Af6zHiHtWtPMbegGCPCHnJ5_PPp3W8xUKdVRMbOqGK89Z4lrbFIJiVnSpgwxvOhZUG2USIghuU5TKRK-D9LZjkK-4R9ZuCP-n5KCHkT4ntOmCMiGr3ArfqpaZFGzQ2jRdUjpyVRG2U6mLM784XnNx4co6wyg3WcGBFRxawV1X5P3-lcuJXONvnT-infYdkRe7PABvcbO3uH95S0XeoZUdRi8MLvr5TwggIvJguWNpmeatYSDO4aInRF1cNu_8xM1RPzqAQ6BMAGjwO2_2zfgmVrL1edhiH4EQnIm2Is8mt9qLhMxHFiBDRfTC4RYyL1v69ffCCa4ACWtuKvJh55q_hvVHlb74Hyp9Se7xElgKYuuQHGyutvkVALVNeF1i8idsIDi4
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3daxQxEA9aQXwRrR9drRJBEJSl2WQ3yT5JFUsR9KmFewv5Wj0ou-ftXR_613cml7u6FQsHB5ssZDKfmcz-hpD3YPSj9p0tOx_rsg4tLy2vROl8w7x2EJTbVG3xU56e199nzSwn3MZcVrm1iclQh8FjjvwIXI3gLTg__nnxp8SuUXi7mlto3CcPEnQZyLOa7Q5cFWLB5ZvMSsujEXMuWIjQlkxoWV5NfFGC7P_XMP_lmW5XTd66Ok0e6eQJeZxDSXq84f1Tci_2-9iFOVds7JOHP_LF-TMyOxsgyqY2zBdDjzaup_AbUlU0Hs-p7QMdXBwjHdcOczNjejSH_-WmjDbS1UAv56PHLBbt7IpeAFHPyfnJt7Ovp2VuqlB6ycSqrLi0nAWuVBuck6wVXejA5-uOOVn7JgjhYKODb6T2VrnGth0DD8Yt4niDQXhB9npY6QGhVeekdlHGWtha1kwH1zqldNUFqTyXBWHb7TU-I45j44sLk04eWpoNRwxwxCBHzFVBPu5eWWzgNu6a_AV5tpuISNnpwbD8ZbLiGRctHEmlbRolIPiyrlOVVRHitMY1seIF-YAcN6jPsDhv82cJQCIiY5njpmWK15oBOYeTmaCHfjq8lRmT7cBobqS2IO92w_gm1rb1cVjjHIFBORN1QV5uRGxHEmIhtRBEFERNhG9C83Skn_9OKOESYmPFdUE-bcX0Zln_3dJXdxPxmjziSX0kaNAh2Vst1_ENBGUr9zZp3jV7vjQs
  priority: 102
  providerName: ProQuest
– databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3ta9YwEA86QfwivtttSgRBUIpp0rz04xyOIeinDZ5vIUkTfGC0Y-3jh_313qV9Htf5AkKh0FxoLneX-yV3vRLyFhb9aEJyZQqxLuu24aXjlSh9kCwYD6Dc5WyLb-r0vP6ykqu5WDR-C3Mzfl8Z9XHAcxJMHmhKJowqr--Se7ISKsdl1fEuYIBl3-ag5R-7LdxOrs7_-xp8wwndTpC8FSXNzufkEXk4o0Z6NIn5MbkTuyfk_tc5Lv6UrM56ANHUtevLvsMlrKNw9TnpGXff1HUt7X0cIh02Ho9ehvxoDferKUs20rGnP9ZDwEMqmtxIL4CRZ-T85PPZ8Wk5_zOhDIqJsay4cpy1XOum9V6xRqQ2gUs3iXlVB9kK4QVv2iCVCU576ZrEwEFxh2W6wd6fk70ORvqS0Cp5ZXxUsRauVjUzrW-81qZKrdKBq4Kw7ZTaMBcUx_9aXNi8sTDKTlKwIAWLUrDXBXm_63I5VdP4F_EnlNOOEAth5wegH3a2K-ujgx2nclJqAdjK-aQrpyPAMOllrHhB3qGULZorDC64-asDYBELX9kj2TDNa8OAncMFJZhZWDZv9cTOZj5YwD8wmYDI4D1vds3YE1PXuthvkEYg5maiLsiLSa12LGGpowYwQkH0QuEWPC9buvX3XARcAfTV3BTkw1Y1fw3rr1O6_1_UB-QBzxakwIgOyd54tYmvAIKN_nU2vp_TcCmA
  priority: 102
  providerName: Springer Nature
Title Total adiponectin in overweight and obese subjects and its response to visceral fat loss
URI https://link.springer.com/article/10.1186/s12902-019-0386-z
https://www.ncbi.nlm.nih.gov/pubmed/31159801
https://www.proquest.com/docview/2243295542
https://www.proquest.com/docview/2235071034
https://pubmed.ncbi.nlm.nih.gov/PMC6545728
https://doaj.org/article/bea1916a5573439abf71a7e3895b5e12
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swED_6AaUvY9_z1gUPBoMNb7JkS_LDGE1oKYOWURoIexGSLG-BYHdxMrb-9Tspdrp07SAkxJKITnen-510uQN4jZu-k7bSSWVdlmRlQRNNU5YYmxMrDYJyHaItzvjJOPs8ySdb0Je36hawvdW18_WkxvPZ-18_fn9Chf8YFF7yD60_S_EBBkVCmOTJ1TbsomHi3hc7za4vFXxquO5i89Zh-7Dnc88UsqsQ01upkMz_3y37L5t1M57yxqVqsFXH9-FeBzLjw5VUPIAtVz-EvdPuGv0RTC4aJDfW5fSyqf2OV8f4akKMtHfWY12XcWNc6-J2afxJTRseTfFzvgqqdfGiiX9OW-vPtOJKL-IZEvIYxsdHF6OTpCuxkFhO2CJJKdeUlFSIojSGk4JVZYUIQFbE8MzmJWOG0aK0OZdWC5ProiJoz6j2Wb1xe3gCOzXO9BnEaWW4NI67jOmMZ0SWpjBCyLQqubCUR0D6JVW2yz_uy2DMVPBDJFcrhihkiPIMUVcRvF0PuVwl3_hf56Hn07qjz5sdHjTzb6pTQ2WcRgeV6zwXDKGYNpVItXCI2nKTu5RG8MZzWXl5w8lZ3f1JAUn0ebLUYV4QQTNJkJyDjZ6olXazuZcT1Qu1QriEi4kADn_n1brZj_SRbrVrlr4P8xCdsCyCpyuxWpPUS2cEYkPgNmjebKmn30POcI5IWVAZwbteNK-ndeeSPr9zBi9gnwbF4ag7B7CzmC_dS0RnCzOAbTERA9gdHp19OcdvIz4ahJOOQdBGfD8ffv0DfT047g
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1db9Mw0BqdBLwgGF-BAUYCIYGiJU5iOw8IbbCpY1uFUCf1zdiOs1WaktK0IPaj-I3c5aMjQ-xtUqVKsdP6fN_n8x0hr0DoO2lz7efWxX6cpczXLIx8Y5PASgNGua6zLUZ8eBx_niSTNfK7uwuDaZWdTKwFdVZajJFvgaqJWArKj32YffexaxSernYtNBqyOHC_foLLVr3f_wT4fc3Y3u7449Bvuwr4lgfRwg8Z1yzImBBpZgwHjz7PclB6Mg8Mj22SRZGBf8pswqXVwiQ6zQMQ4UxjIWvgCPjdG2Q9xhutA7K-szv68nV1boHV59qz01DyrQqjPJj6kPpBJLl_3tN-dZOAf1XBX7rwcp7mpcPaWgfu3SV3WuOVbjfUdo-suWID-z63OSIb5OZRe1R_n0zGJdj1VGfTWVmgVC0ofMo6DxsDAlQXGS2NqxytlgajQVX9aArf8yZx19FFSX9MK4txM5rrBT0DoB6Q42vZ8IdkUMBKHxMa5oZL47iLIx3zOJCZSY0QMswzLizjHgm67VW2rXGOrTbOVO3rSK4ajCjAiEKMqHOPvF29MmsKfFw1eQdxtpqItbnrB-X8RLWsrozT4ARznSQiAnNPm1yEWjiwDBOTuJB55A1iXKEEgcVZ3V6EABCxFpfaTtJAsFgGAM5mbyZwvu0PdzSjWslTqQs-8cjL1TC-idl0hSuXOCdCNyCIYo88akhsBRJWX0rBbPGI6BFfD-b-SDE9reuSc7DGBZMeedeR6cWy_rulT64G4gW5NRwfHarD_dHBU3Kb1azEgZs2yWAxX7pnYBIuzPOWDyn5dt2s_wcVY3Iv
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9wwEBZtCqGX0nfdpq0KhUKLiSzZknxM0y7pK_SQwN6EJEvpQrCXtTeH_PrM2N5tnT6gsGCwJFaj0Wg-acafCHkNi37QPto0-pCneVXy1PJMpM4XzGsHoNz22RbH8ug0_zwv5uM9p-0m230Tkhy-aUCWprrbX1ZxMHEt91s8PcGUgjJlQsv08ia5laPnw2itPNyGEZAMbgxl_rHZxBn1nP2_r8y_uKbraZPXYqe9S5rdJXdGLEkPBuXfIzdCfZ_sfhuj5Q_I_KQBaE1ttVg2NS5sNYVf06dC456c2rqijQttoO3a4YFM279awHM15M4G2jX0YtF6PLqi0Xb0HAR5SE5nH08Oj9LxJoXUSya6NOPSclZxpcrKOclKEasIjl5H5mTui0oIJ3hZ-UJqb5UrbBkZuC1ukbwbVoFHZKeGnj4hNItOahdkyIXNZc505UqnlM5iJZXnMiFsM6TGjzTjeNvFuem3G1qaQQsGtGBQC-YyIW-3TZYDx8a_Kr9HPW0rIj12_6JZnZnR2owLFvah0haFEoC4rIsqsyoAOCtcETKekDeoZYNGDJ3zdvwWAUREOixzUJRM8VwzEGdvUhOMz0-LN_PEjMbfGkBFMJiA0-B_Xm2LsSUmtNWhWWMdgUiciTwhj4dptRUJCZBKQA4JUZMJN5F5WlIvfvTU4BIAseI6Ie82U_Nnt_46pE__q_ZLsvv9w8x8_XT85Rm5zXtjkmBPe2SnW63Dc8BonXvR2-EVmM80tA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Total+adiponectin+in+overweight+and+obese+subjects+and+its+response+to+visceral+fat+loss&rft.jtitle=BMC+endocrine+disorders&rft.au=Gariballa%2C+Salah&rft.au=Alkaabi%2C+Juma&rft.au=Yasin%2C+Javed&rft.au=Al+Essa%2C+Awad&rft.date=2019-06-03&rft.eissn=1472-6823&rft.volume=19&rft.issue=1&rft.spage=55&rft_id=info:doi/10.1186%2Fs12902-019-0386-z&rft_id=info%3Apmid%2F31159801&rft.externalDocID=31159801
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1472-6823&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1472-6823&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1472-6823&client=summon